Phosphorus P 32 use while Breastfeeding

Summary of Use during Lactation

Information in this record refers to the use of phosphorus P 32 as a therapeutic agent. No information is available on the use of phosphorus P 32 during breastfeeding. Use of phosphate P 32 as a skin patch to treat skin cancers poses no risk to breastfed infants after removal of the patch from the mother's skin

Drug Levels

Phosphorus P 32 decays by beta emission with an energy of 1.709 MeV and a half-life of 14.3 days.[1]

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.

Mountford PJ, Wells CP, Hall FM, et al. Potential radiation dose to a breast-fed infant following administration of sodium 32P-phosphate to the mother. Nucl Med Commun. 1984;5:473–6. [PubMed: 6531156]

Substance Name

Phosphorus P 32

CAS Registry Number

14596-37-3

Drug Class

Breast Feeding

Lactation

Radiopharmaceuticals

Phosphorus Radioisotopes